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A single-center prospective cohort study was designed to
identify alterations of renal function during childhood in
children born prematurely. A cohort of 143 such babies born
over a 4-year period (birth weight less than 1000g and/or
less than 30 weeks of gestation) was prospectively included
at birth. A mailing was sent to all parents to propose renal
evaluation. Among the 50 included children, 23 had intra-
uterine and 16 had extrauterine growth retardation. When
comparing both of these groups to 11 children with
appropriate pre- and postnatal growth at a mean follow-up
of 7.6 years, both groups of growth-restricted children had
slightly but significantly lower glomerular filtration rates,
measured by inulin clearance, although both groups were
still within the normal range for their ages. There were no
differences for other renal parameters, neonatal therapies or
complications, except for postnatal corticosteroid exposure.
Children with extrauterine growth restriction were found to
have significantly lower protein-energy intake during their
first week of life than the intrauterine growth–restricted or
the normotrophic children. Our study found that children
with either intra- or extrauterine growth retardation are at
risk of decreased glomerular filtration rates during childhood.
Extrauterine growth restriction represents a new risk factor
for long-term renal impairment in premature children.
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Long-term renal outcome of children born preterm remains
uncertain.1 Intermediate-term 2–4 and long-term 5–7 evalua-
tions during childhood and early adulthood have shown
subtle changes in the renal function of premature children,
mainly in blood pressure (BP), kidney size, tubular function,
and glomerular filtration rate (GFR). In most of these
studies, GFR is estimated by using Schwartz formula in
children or Cockcroft/MDRD formula in young adults.
However, GFR measurement using exogenous markers, such
as inulin, iothalamate, or iohexol, is recommended despite
technical and financial limitations.8 Moreover, several studies
did not distinguish children according to the presence or
absence of intrauterine growth retardation (IUGR).
In humans, approximately 60% of the nephron popula-
tion develops during the third trimester of gestation.9 Renal
development ends between 35 and 36 weeks of gestational age
(GA) and is influenced by prematurity, leading to ‘oligone-
phropathy’ with quantitative and qualitative alteration of
nephron formation.10 Brenner and Anderson11 suggested an
inverse correlation between the total renal filtration surface
area and the risk of arterial hypertension. This concept of
‘reduction in nephron number’ leads to a progressive renal
impairment: increase of single-nephron glomerular filtration,
compensatory nephron hypertrophy, decrease of functional
reserve, microalbuminuria, arterial hypertension, glomerulo-
sclerosis, overt proteinuria, progressive fibrosis, chronic
kidney disease, and a reduction in nephron number. Further
studies have shown a strong correlation between birth weight
(BW), glomerular number, and glomerular size.12
Barker et al.13 showed that children with IUGR were at
risk of developing metabolic syndrome and cardiovascular
disease in adulthood. Moreover, the clinical course of some
glomerular diseases (for example, IgA nephropathy, mem-
branous nephropathy, and minimal change nephrotic
syndrome) is influenced by IUGR.14,15
Recent studies have also emphasized the importance of
extrauterine growth retardation (EUGR), usually defined as a
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height or weight below the 10th percentile at discharge from
the neonatal intensive care unit, in children born with an
appropriate BW for GA.16 The pathophysiology of EUGR
remains unclear, involving both genetic and environmental
factors. However, EUGR is linked to early protein-caloric
deficiency,17 BW,18 gender, need for mechanical ventilation,
necrotizing enterocolitis, and exposure to neonatal corticos-
teroids.16 It may also be associated with impaired long-term
growth and with lower psychomotor development at 2 years
of age.19,20 Recent animal studies have suggested that
restriction of both perinatal and early postnatal growth
may increase BP in male rats,21 but renal consequences of
EUGR in humans remain unknown.
The aim of this study was to investigate the renal outcome
of children born preterm in a single-center cohort and to
identify risk factors predictive of intermediate-term renal
impairment.
RESULTS
The flowchart of the study is summarized in Figure 1. Fifty
children underwent the renal exploration. There were no
significant differences between included children and those
from the cohort whose parents did not answer (Table 1),
particularly in terms of BW, GA, proportion of IUGR,
proportion of morbidities (bronchopulmonary dysplasia,
patent ductus arteriosus, sepsis, periventricular leucomalacia,
and necrotizing enterocolitis), perinatal nutrition, and drug
exposure.
In the cohort of 50 children undergoing the renal
exploration, that is, BP assessment, inulin clearance, tubular
explorations, and renal ultrasounds (Table 2), the mean age
at renal assessment was 7.6±1.3 years (5.8–10.3). During the
neonatal period, no child experienced severe oliguria or
required renal replacement therapy. There were 23 (46%)
children with severe IUGR and 16 (32%) with severe EUGR;
only 44 inulin clearance tests were available because of
technical problems (failure of venous puncture or timed
collection of urine). No child had significant arterial
hypertension. The 95% confidence interval for mean diastolic
BP percentile was above the 50th percentile (51–65), whereas
the 95% confidence interval for mean systolic BP percentile
included the 50th percentile (38–53). The true GFR was above
90 ml/min per 1.73 m2 in all cases, with a mean inulin
clearance of 112 ml/min per 1.73 m2 (91–158). The mean
urine calcium-to-creatinine ratio was 0.3 mmol/mmol
(0.02–1.28). Two children had hypercalciuria (a urine
calcium-to-creatinine ratio40.9 mmol/mmol): one child
received acetazolamide because of hydrocephalus and the
other suffered from post-necrotizing enterocolitis chronic
malabsorption with hyperoxaluria and hypercalciuria. Two
children had moderate microalbuminuria. There was no
obvious tubular dysfunction but b2-microglobulinuria
(40.20 mg/l) was present in eight patients (17%). Ultra-
sounds revealed more small-sized kidneys than expected,
when expressing kidney size in percentile according to statural
height: the 95% confidence interval for the mean standard
deviation score (SDS) of kidney size according to height was
(1.3; 1.9) for the right kidney and (1.1; 1.6) for the left
kidney. In addition, ultrasounds revealed moderate cortical
nephrocalcinosis in a 7-year-old girl with renal hypodysplasia
and three undiagnosed silent malformations.
A comparison between IUGR (n¼ 23), EUGR (n¼ 16),
and children with normal pre- and postnatal growth (n¼ 11)
was performed (Tables 2 and 3). There were no differences
among these three groups in terms of prenatal corticoster-
oids, oligohydramnios, umbilical venous and arterial cathe-
ters, neonatal drug exposure, and neonatal complications,
except bronchopulmonary dysplasia (EUGR 63%, IUGR
35%, and normotrophic 18%, P¼ 0.054) and postnatal
corticosteroid exposure (EUGR 50%, IUGR 17%, and
normotrophic 9%, P¼ 0.026). Moreover, maximal blood
urea nitrogen in EUGR children was greater (EUGR
13.3±5.1, IUGR 10.2±8.2, and normotrophic
11.8±3.4 mmol/l, P¼ 0.011), whereas they received less
protein-calorie intakes at 7 days of life. This difference was
not present at 14, 21, and 28 days. The final results of inulin
clearance were available in 12 children with EUGR, in 21
children with IUGR, and in 11 normotrophic children with
normal postnatal growth. IUGR and EUGR children
experienced a comparable decreased GFR (however, within
the normal range) without any other differences for BP, renal
size, urine calcium-to-creatinine ratio, and microalbumin-
uria. Figure 2 represents the relation between growth
retardation and GFR.
Univariate analysis of intermediate-term renal abnormal-
ities (BP, GFR, microalbuminuria, urine calcium-to-
creatinine ratio, and kidney size) according to different
neonatal conditions, mainly morbidities (bronchopulmonary
dysplasia, patent ductus arteriosus, and bacterial-
proven sepsis) and therapies, was performed. Children with
bronchopulmonary dysplasia were at risk of impaired
intermediate-term renal function (higher microalbuminuria:
2.1±1.5 vs 1.2±0.8 mg/mmol, P¼ 0.013), without any
difference for GFR (108±8 vs 115±17 ml/min per 1.73 m2,
P¼NS). There were no differences for intermediate-term
renal parameters between children with and without patent
Prospective nutritional cohort 
N = 143
Siblings (from multiple 
pregnancies)
N  = 13
Review of all prenatal and 
neonatal data
N  = 142
Mailing 
N  = 129
Lost file
N  = 13
First consultation 
N  = 57
Renal exploration 
N  = 50
No available or 
correct address 
N  = 13
Death after 
discharging 
N  = 1
Figure 1 | Flowchart of the study.
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ductus arteriosus (for example, GFR: 109±9 vs 113±16 ml/
min per 1.73 m2, P¼NS) and between children with and
without neonatal bacterial-proven sepsis (for example, GFR:
110±13 vs 113±15 ml/min per 1.73 m2, P¼NS). There were
no differences for intermediate-term renal parameters bet-
ween children who were and were not exposed to cortico-
steroids (antenatal and postnatal), non-steroidal anti-inflam-
matory drugs, diuretics, vancomycine, and aminoglycosides
(during the neonatal period and after the first 48 h of life).
After adjustment for calorie intake at day 7, the presence
of main comorbidities (that is, patent ductus arteriosus,
bacterial-proven sepsis, and bronchopulmonary dysplasia)
and therapies (that is, ibuprofen and early postnatal
corticosteroids), the multiple linear regression analysis
showed that GFR remained significantly lower both in IUGR
and in EUGR children, in comparison with normotrophic
children (19.5 and 15.4 ml/min per 1.73 m2, with absolute
95% confidence intervals of 8.5–30.5 and 2.4–28.3,
Table 1 | Comparison of neonatal parameters among 50 children with renal assessment and 92 children whose parents did not
answer
Patients with renal
assessment
(mean±s.d. or %)
Children without
renal assessment
(mean±s.d. or %) P-value N
Number of patients 50 92 142
Birth
Gestational age (weeks) 27.3±1.97 27.3±1.64 0.98 142
Birth weight (g) 855±210 847±201 0.69 142
Birth size (cm) 34±3 34±3 0.98 142
Birth head circumference (cm) 24±2 24±2 0.88 142
Oligohydramnios (%) 21 24 0.63 138
IUGR (%) 46 42 0.68 142
Cesarean (%) 76 76 0.95 140
Antenatal corticosteroids (%) 78 74 0.61 139
First days
Patients with umbilical venous catheter (%) 66 77 0.15 142
Patients with umbilical arterial catheter (%) 66 59 0.39 142
Therapies received during the neonatal period
Ibuprofen (%) 16 14 0.76 142
Indomethacin (%) 36 50 0.11 142
Vasoactive drugs (%) 8 9 0.89 142
Postnatal corticosteroids (%) 26 33 0.41 142
Furosemide more than 5 consecutive days (%) 8 13 0.36 142
Spironolactone+HCT (%) 12 15 0.6 142
Vancomycin (%) 36 50 0.11 142
Amikacin after the first 48 h of life (%) 38 47 0.32 142
Neonatal morbidities
Duration of oxygene therapy (h) 461±562 527±734 0.87 140
Duration of ventilation (h) 198±295 218±281 0.31 141
Leucomalacia (%) 2 2 0.95 142
Stage III or IV intraventricular hemorrhage (%) 0 4 0.14 142
Necrotizing enterocolitis (%) 2 4 0.47 142
Bacterial-proven infection (%) 22 21 0.85 142
Bronchopulmonary dysplasia (%) 40 52 0.17 142
Patent ductus arteriosus (%) 26 39 0.12 142
Maximal blood urea nitrogen (mmol/l) 11.6±6.5 12.6±6.5 0.2 141
Discharge
Postnatal age at discharge (days) 79±29 85±32 0.4 140
Weight (g) 2334±463 2411±597 0.39 140
Size (cm) 43.7±2.9 44.2±3 0.42 138
Head circumference (cm) 32.7±1.8 32.8±4.1 0.24 133
Nutritional data
Maximal neonatal weight loss (%) 15.1±6.2 12.8±6.7 0.039 142
Duration of initial parenteral nutrition (days) 22±18 25±19 0.89 139
Proportion of patients receiving secondary parenteral nutrition (%) 10 10 0.97 142
Insulin therapy (%) 44 45 0.95 142
Day 7
Daily total protein intake (g/kg/day) 2.65±0.62 2.64±0.51 0.55 141
Daily total caloric intake (kcal/kg/day) 95.5±25.7 93.7±20.2 0.76 141
Weight (g) 776±196 786±152 0.29 141
HCT, hydrochlorothiazide; IUGR, intrauterine growth retardation.
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and P¼ 0.001 and 0.02, respectively). For microalbuminuria,
the unique determinant that remained significant in a
multivariable model was bronchopulmonary dysplasia
(P¼ 0.007).
DISCUSSION
This study population is based on only 50 children;
however, the reference standard for GFR (inulin clearance)
was performed in a prospective single-center cohort
with neonatal exhaustive and accurate parameters. A
selection bias regarding included and non-included children
is unlikely as there is no significant difference in the neonatal
period in terms of general characteristics, anthropometric
items, morbidities, and drug exposure. However, there
was a trend toward a higher prevalence of broncho-
pulmonary dysplasia and patent ductus arteriosus in the
children who did not vs those who did have renal evaluation.
These two entities could represent significant risk factors
for adverse renal outcomes, mainly bronchopulmonary
dysplasia. Although not statistically different, the possibility
that the final cohort studied underestimates intermediate-
term renal dysfunction in children born preterm should
nevertheless be hypothesized, reinforcing the need of a renal
follow-up of all children born very preterm.
In the cohort of the 50 included children, all had a true
GFR (inulin clearance) above 90 ml/min per 1.73 m2.
However, as illustrated in Figure 1, seven children declined
to participate between the first and the second visit, corres-
ponding respectively to the ‘inclusion’ visit and the renal
exploration, and did not want to undergo inulin clearance
anymore: among them, three children had an impaired esti-
mated GFR (eGFR) (two bilateral hypodysplasia, one chronic
renal insufficiency following neonatal acute renal insuffi-
ciency; respective eGFR 59, 69, and 76 ml/min per 1.73 m2);
all three nevertheless required a specific medical follow-up. It
would have been interesting to have age-matched controls to
Table 2 | Renal evaluation in the total cohort and in IUGR, EUGR, and normotrophic children
Normal
values
Total cohort
N=50
Normotrophic
children,
N=11 EUGR N=16 IUGR N=23
Parameters N Mean±s.d. Mean±s.d. Mean±s.d. Mean±s.d. P
Age (years) 50 7.6±1.3 6.8±0.9 7.9±1.3^ 7.8±1.3* o0.05
Weight (kg) 50 22.9±5.2 21±5.1 24.7±4.3 22.6±5.7 NS
SDS for weight 50 0.2±2.2 0.2±2.9 0.35±1.7 0.6±2.1 NS
Height (cm) 50 121±8 117±8 124±6 121±9 NS
SDS for height 50 0.2±1.2 0.1±1.4 0.2±1.2 0.5±1.1 NS
Systolic BP (mmHg) 50 100±9 98±9 102±6 99±11 NS
Percentile for systolic BP 50 46±26 47±27 49±20 43±31 NS
Diastolic BP (mmHg) 50 58±7 59±8 60±6 58±8 NS
Percentile for diastolic BP 50 58±24 59±28 62±18 54±26 NS
Inulin clearance (ml/min/1.73m2) 44 117±16 112±14 125±17 110±13^ 107±9* o0.05
Chloride RR (%) 46 98.47±0.27 98.56±0.55 98.56±0.56 98.61±0.66 98.52±0.48 NS
Sodium RR (%) 46 99.13±0.54 99.14±0.37 99.0±0.41 99.23±0.41 99.14±0.31 NS
Potassium RR (%) 46 83.61±7.17 90.56±4.51 93.18±3.48 89.54±4.60 90.04±4.58 NS
Phosphate RR (%) 46 90.3±5.1 91.86±2.94 92.29±3.82 92.99±2.36 90.85±2.61 NS
TmP/GFR (mmol/l) 46 1.05–1.72 1.42±0.18 1.35±0.13 1.48±0.22 1.41±0.17 NS
Uric acid clearance
(ml/min/1.73m2)
47 12.4±3.2 12.6±4.4 14.4±4.9 13.4±5.0 11.0±2.9 NS
Urine maximal osmolality
(mOsm/kg)
47 4700 799±219 901±188 774±256 765±197 NS
Urine calcium:creatinine ratio
(mmol/mmol)
47 0.04–0.7 0.33±0.24 0.44±0.36 0.31±0.22 0.28±0.17 NS
Urine albumin:creatinine ratio
ratio (mg/mmol)
47 o2 1.58±1.25 1.9±1.6 1.6±1.1 1.5±1.2 NS
Urine magnesium:creatinine ratio
(mmol/mmol)
47 0.3–0.9 0.59±0.21 0.70±0.22 0.53±0.20 0.58±0.19 NS
Serum cystatin C (mg/l) 48 0.5–1.3 0.74±0.1 0.71±0.08 0.74±0.10 0.75±0.11 NS
Serum uric acid (mmol/l) 48 120–400 226±47 216±49 214±48 240±44 NS
Right/left renal length (mm) 44 75±8/77±8 75±7/76±8 76±5/79±6 74±10/78±7 NS
SDS for right/left renal length 44 1.6±1/1.4±0.9 1.2±1.1/1.3±0.8 1.7±0.9/1.4±1 1.7±1/1.4±0.9 NS
Proportion of uropathies (%) 44 8 9 12 4 NS
ANOVA, analysis of variance; BP, blood pressure; EUGR, extrauterine growth retardation; IUGR, intrauterine growth retardation; RR, reabsorption rate; SDS, standard deviation
score; TmP/GFR, maximal tubular phosphate reabsorption/glomerular filtration rate.
P, ANOVA or Kruskall Wallis tests when comparing normotrophic, EUGR, and IUGR children.
*Po0.05 normotrophic vs IUGR.
^Po0.05 normotrophic vs EUGR.
#Po0.05 IUGR vs EUGR.
Normal values according to Hatos’ references29 and local normal references.
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compare inulin clearance in children born preterm and full
term. However, it was ethically not possible to propose inulin
clearance to healthy pediatric controls.
The mean diastolic BP is significantly higher in compar-
ison with expected values. The clinical relevance of such a
difference can be discussed (for a height of 120 cm in male
individuals, the difference between the 50th percentile and
the 58th percentile of diastolic BP is only 4 mm Hg).
However, this may be amplified along with age and may
lead to a further impact during adulthood. Moreover, in
adults, data from observational studies and randomized
controlled trials have suggested that lowering population-
wide diastolic BP by only 2 mm Hg could result in a 17%
decrease in the prevalence of arterial hypertension, as well as
a 6% decrease in the risk of coronary heart disease, and a
15% reduction in the risk of stroke and transient ischemic
attacks.22
The combination of a diastolic BP within the upper
normal range and kidney size within the lower normal range
after adjustment on height indicates the presence of subtle
abnormalities, possibly secondary to a reduction in nephron
number. The absence of change in GFR cannot preclude
reduced nephron number in any or all of the groups, as it is
well known both in animal models and in humans that a
nephron deficit of moderate degree often yields normal GFR
during childhood. Overall, our results are consistent with
previous studies showing a discrete but early renal impair-
ment in children born preterm. However, they cannot
provide direct information on the true nephron number in
these children, as there were no available data on renal shape
and there were no direct glomerular counts. Moreover, all
these children were born very preterm and mostly likely all
had a lower number of nephrons than did full-term children.
As their GFRs were all in the normal range, relative to a likely
low number of nephrons, all these children may have a high
single-nephron GFR, thus putting all of them at risk for long-
term renal impairment, according to Brenner’s hyperfiltra-
tion theory.11
The high proportion of children with IUGR (46%) is
similar as that observed in other studies; in the literature,
30–50% of extremely preterm neonates are IUGR.23. A
comparable alteration of GFR in both EUGR and IUGR
patients is indeed remarkable. Nevertheless, the patho-
physiology of such intermediate-term renal impairment is
Table 3 | Neonatal parameters according to EUGR, IUGR, or normotrophic status
Normotrophic children, N=11 EUGR, N=16 IUGR, N=23
Parameters N Mean±s.d. Mean±s.d. Mean±s.d. P-value
Birth weight (g) 50 1039±278 845±146^ 773±155* o0.05
Gestational age (weeks) 50 27.1±1.8 26.2±1.8# 28.2±1.8 o0.05
Proportion of boys (%) 50 46 63 35 NS
Children with venous UC (%) 50 46 63 78 NS
Children with arterial UC (%) 50 64 81 57 NS
Protein intake day 7 (g/kg/day) 50 2.9±0.6 2.2±0.5^,# 2.8±0.5 o0.05
Calorie intake day 7 (kcal/kg/day) 50 111±21 79±19^,# 99±26 o0.05
Parenteral water intake day 7 (ml/kg/day) 50 77±48 125±33^,# 100±32 o0.05
Total water intake day 7 (ml/kg/day) 50 147±13 150±19 141±21 NS
Protein intake day 14 (g/kg/day) 50 3.2±0.8 2.9±0.7 3.0±0.5 NS
Calorie intake day 14 (kcal/kg/day) 50 109±30 105±27 117±37 NS
Protein intake day 21 (g/kg/day) 50 3.1±0.5 3.0±0.7 3.0±0.7 NS
Calorie intake day 21 (kcal/kg/day) 50 124±24 111±24 122±29 NS
Age at discharge (days) 50 72±33 88±23 76±31 NS
Weight at discharge (g) 50 2523±636 2408±379 2191±391 NS
SDS for weight at discharge 50 0.9±0.6 1.8±1^,# 2.5±1* o0.05
SDS for height at discharge 50 1.2±0.5 2.7±0.5^,# 3.6±0.7* o0.05
ANOVA, analysis of variance; EUGR, extrauterine growth retardation; IUGR, intrauterine growth retardation; SDS, standard deviation score; UC, umbilical catheter.
P, ANOVA or Kruskall–Wallis tests when comparing normotrophic, EUGR, and IUGR children.
*Po0.05, normotrophic vs IUGR.
^Po0.05, normotrophic vs EUGR.
#Po0.05, IUGR vs EUGR.
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Figure 2 |Relationship between perinatal growth and
intermediate-term glomerular filtration rate. IUGR: intrauterine
growth retardation. EUGR: extrauterine growth retardation.
*Po0.05.
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unclear. In IUGR children, the reduction in nephron number
is at least partially explained by in utero mechanisms
involving vascular changes. It would have been interesting
to individualize IUGR children with early catch-up growth
before discharge from the neonatal intensive care unit from
others (that is, to study four different groups: normotrophic
children, EUGR children, IUGR with early neonatal catch-up
growth, and IUGR with additional EUGR); however, the
population was too small to perform such an analysis.
Having only 11 children in the control group of very
preterm children with normal BW for GA and with normal
postnatal growth represents a limitation for this study. Results
are nevertheless statistically significant, with a comparable
decrease of GFR in IUGR and EUGR children, however, within
the normal range. This slight decrease of GFR could
correspond to a moderate reduced nephron number, clinically
asymptomatic during childhood. This moderate decrease
could nevertheless be of importance during adulthood as
GFR decreases every year by 1 ml/min from the age of 40 years.
Moreover, even if a reduced nephron number is present in
these children, it could reflect either impaired primary
nephrogenesis or secondary loss of nephrons due to toxic or
hemodynamic injuries during the neonatal period. Another
hypothesis could be a relative greater degree of hyperfiltration
in normotrophic children; however, mild hyperfiltration was
found in two normotrophic children (GFR 143 and 158 ml/
min per 1.73 m2) and in one IUGR child (GFR 147 ml/min per
1.73 m2). Furthermore, this hypothesis seems unlikely as IUGR
is a well-known risk factor of long-term renal impairment.
EUGR and IUGR groups at the time of the study were
older (by a full year on average) than the normotrophic
group. However, inulin clearance adjusted for average adult
body surface area is stable over the age range studied.24 Given
the age differences between the three groups, body weight
and height were expressed in SDS. For the same reason, BP
and renal size were adjusted on statural height.
In this study, EUGR children had a lower GA and a lower
BW than babies with normal pre- and postnatal growth. Even
if total water intake was not different on day 7, parenteral
water intake in EUGR children was significantly higher,
suggesting that these children were more severely ill during
the first week of life. Moreover, they also received postnatal
corticosteroids more often and suffered more often from
bronchopulmonary dysplasia, as previously reported.16 An
early deficiency of protein-calorie intake (during the first 7
days of life) may have a role in the pathophysiology of both
EUGR and intermediate-term renal impairment of EUGR
and could explain the reduced nephron number in these
patients. This early proteinocaloric deficiency would not
influence long-term growth and catch-up in these children.
Furthermore, it could be an early neonatal explanation for
the reduced nephron number as Rodriguez et al.10 showed on
histopathological studies that glomerulogenesis occurred
only in the first 40 days after birth in very preterm children,
suggesting the importance of early postnatal factors in the
late nephrogenesis of preterm children.
Moreover, these results of a long-term renal impairment in
case of neonatal growth retardation are consistent with the
hypothesis of Yeung9 who speculated in 2006 that, in very
preterm newborns with prolonged early postnatal growth
deceleration as a consequence of undernutrition, oligone-
phropathy could occur due to a protein-calorie deficiency.
Most neonatal intensivists have recently increased protein-
calorie intake during the first days of life; thus, in the future,
the comparison of this cohort with more recent cohorts will
confirm the true impact of protein-calorie intake on renal
development in children born preterm.
In univariate and multivariate analysis, despite the
population size, bronchopulmonary dysplasia seems to be
associated with intermediate-term subtle renal abnormalities,
partly due to EUGR. No drug seems to be associated with
renal impairment during childhood, whereas Rodriguez-
Soriano et al.2 discussed the role of early exposure to
aminoglycosides in the genesis of intermediate-term hyper-
calciuria. In our study, all but one child received aminoglyco-
sides during the first 48 h of life (due to local protocol
antibiotic therapy at birth in premature children between
1998 and 2001); there were no differences for intermediate-
term renal parameters between children who were and were
not exposed to aminoglycosides during the neonatal period
and after the first 48 h of life.
In conclusion, although GFR is normal during childhood
in children born preterm, borderline BP and reduced kidney
size can be regarded as markers of the reduced nephron
number. This hypothesis is reinforced by a lower GFR in both
IUGR and EUGR children. In addition to IUGR, EUGR may
represent a new risk factor for long-term renal impairment in
children born preterm. The pathophysiology of such an
impairment may be attributed to an early relative deficit in
protein-calorie intake. As the reduction in nephron number
may have long-term consequences, three conclusions can be
drawn. First, pediatricians may perform an early prevention
focused on cardiovascular risks, nutrition (mainly protein
and salt intakes), and obesity. Nephrotoxic drugs may be
avoided, particularly non-steroidal anti-inflammatory thera-
pies. A follow-up of renal parameters (BP yearly, serum
creatinine and microalbuminuria every 5 years) may be
performed in these children who should be referred when
abnormalities have been highlighted. Second, adult nephrol-
ogists may keep in mind that children born very preterm in
the 1980s have become young adults; thus, in case of chronic
kidney disease without any evident etiology, BW and GA
should be recorded. Finally, large prospective studies are
required: even if comparisons of different early neonatal
protein-calorie intakes will be difficult to drive, randomized
controlled trials aiming at evaluating the role of early
nephroprotection may be performed.
MATERIALS AND METHODS
A single-center cohort of 143 premature babies born between 1998
and 2001 (o1000 g and/or o30 weeks GA) was prospectively
included at birth in a database of nutritional parameters. All
450 Kidney International (2009) 76, 445–452
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recorded parameters are summarized in Figure 3. SDS for neonatal
anthropometric parameters were assessed according to Usher and
McLean charts.25 Severe IUGR was defined as a BWp2 SDS for
GA and severe EUGR as a normal BW for GA and a weight or height
at dischargep2 SDS for the corrected GA. Normotrophic children
corresponded to premature children from this cohort with a BW
above the limit of 2 s.d. for GA and a birth and a height at
discharge from the neonatal intensive care unit above the limit of
2 s.d. for their corrected GA. The ‘corrected GA’ was defined
as the ‘age the child would be if the pregnancy had actually gone
to term.’
A mail was sent in 2007 to all parents to propose an evaluation of
kidney function, including BP assessment, renal ultrasonography,
tubular tests, and GFR measurement using inulin clearance. When
parents agreed to enroll their child, a first visit was proposed to
explain the study. A second visit was then scheduled for renal
evaluation. The study was approved by an independent ethical
committee (Comite´ de Protection des Personnes Lyon Sud Est II)
and informed consent was obtained after written information had
been given.
Anthropometric parameters during childhood were evaluated
according to national French growth charts. BP was measured three
consecutive times with an automatic device (Dynamap, GE
Healthcare Dinamap, Procare Monitor, Velizy, France). The lower
diastolic BP and the lower systolic BP were recorded. Arterial
hypertension was defined as a BP above the 97.5th percentile.
Percentiles for BP were determined according to statural height and
gender, and SDS for renal length were determined according to
statural height.26,27 Serum creatinine was measured with a
colorimetric compensated method (kinetic Jaffe, Modular, Roche
Diagnosis, Meylan, France). Tubular assessment included phosphate
and uric acid clearance, electrolyte reabsorption rate (chloride,
sodium, potassium, and phosphate), urine magnesium-to-creatinine
Prenatal
data
General
parameters
Antenatal corticosteroids
method of delivery
Presence of oligohydramnios or
polyhydramnios
Neonatal
data
General
parameters
Anthropometric parameters (body weight,
height, head circumference from birth to
discharge, once a week)
Maximal neonatal weight loss
Nutritional
parameters
Oral and intravenous intakes of protein, lipid,
carbohydrate, energy, sodium, calcium, and
phosphate
Daily collection during 3 weeks, followed by
weekly collection during 4–11 weeks
Duration of initial parenteral nutrition and
insulin therapy
Beginning of oral nutrition and weaning
Biological
parameters
Maximal blood urea nitrogen
Hemoglobin level at birth and discharge
Plasma bicarbonate during the second week
of life
Plasma protein concentration at discharge
Calcium and phosphate serum levels at 14
days of age
Drug
exposure
Vasoactive drugs
Ibuprofen/indomethacin
Corticosteroids
Diuretics (furosemide, combination of
spironolactone and hydrochlorothiazide)
Antibiotics (vancomycin, amikacin, and
penicillin)
Maximal caffeine plasma level
Insulin requirement
Morbidities Bronchopulmonary dysplasia
Patent ductus arteriosus
Sepsis
Neurological damage (periventricular
leucomalacia, stage III/IV intraventricular
hemorrhage)
Necrotizing enterocolitis
Others Apgar score
Use and duration of umbilical arterial and
venous catheters
Duration of oxygen therapy, mechanical
ventilation, and continuous positive airway
pressure
Renal
exploration
Clinical data Weight, height, body mass index, and blood
pressure
Biological
data
Inulin clearance, cystatin C
Tubular tests, β2-microglobulinuria
Microalbuminuria
Ultrasounds Renal ultrasounds: kidney size
Figure 3 |Parameters assessed in children.
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Figure 4 |Relation between glomerular filtration rate
measured with inulin clearance (GFR) and that calculated with
locally adapted Schwartz formula (eGFR). (a) Spearman
correlation (r¼ 0.526, Po0.001). (b) Bland and Altman plot, results
for (GFReGFR): 5.3±13.9 ml/min per 1.73 m2 (mean±s.d.). eGFR,
estimated GFR; GFR, glomerular filtration rate.
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ratio, and urine calcium-to-creatinine ratio. Microalbuminuria
(nephelemetry, BM2; Behring Siemens, Paris, France) and b2-
microglobulin (nephelemetry, BM2; Behring Siemens) concentra-
tion were obtained. Plasma cystatin C (nephelemetry, BM2; Behring
Siemens) and plasma osmolality were also recorded. The true GFR
was measured by the clearance of inulin (polyfructosan infusion,
Inutest; Fresenius Kagi, Graz, Austria). A standard technique was
used by a trained staff, with a continuous infusion after a priming
dose of polyfructosan, 30 mg/kg. Water diuresis was induced by oral
administration of 5 ml/kg of water followed by 3 ml/kg every 30 min
combined with an intravenous infusion of 0.9% sodium chloride.
This enabled the patients to spontaneously empty their bladder
every 30 min. Three to four urine samples were collected and a
blood sample was drawn mid-way through each collection period.
Clearance values were obtained from the mean values of three to
four clearance periods. Measurements of plasma and urine
polyfructosan were performed using an enzymatic method. In
children with technical problems with inulin clearance (failure
of venous puncture or timed collection of urine), eGFR was
obtained from a locally adapted Schwartz formula (eGFR¼
33 height (cm)/plasma creatinine (mmol/l)).28 Figure 4 illustrates
the relationship between inulin clearance and eGFR in the cohort
(Spearman correlation, r¼ 0.526, Po0.001; Bland and Altman
plot). Normal ranges were obtained from local normal values and
Matos’ values for tubular parameters.29
Data are presented as mean±s.d. for continuous variables and as
percentage for categorical variables. Univariate comparisons of
continuous variables were performed using an unpaired t-test or the
non-parametric Wilcoxon rank-sum test when covariates were not
normally distributed. Multiple comparisons were performed using
analysis of variance test or Kruskall–Wallis test. Dichotomized variables
were compared using the Pearson w2-test. The Pearson correlation test
was used when data were normally distributed and the Spearman
correlation test was used when they were not. A multiple linear
regression was performed to estimate the relationship between baseline
parameters and renal outcomes (inulin clearance and microalbumi-
nuria). To evaluate the impact of IUGR and EUGR on GFR, a multiple
linear regression analysis was performed after adjustment for main
neonatal morbidities and received therapies. All statistical tests were
performed at the two-sided 0.05 level of significance. Statistical
analysis was performed using the SPSS software 15.0 for Windows.
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